Feasibility and preliminary biomarker responses to capsules containing green coffee extract enriched with magnesium di-malate in women with type 2 diabetes mellitus: a randomized, placebo-controlled pilot trial
Márcio Flávio Moura de Araújo, José Claudio Garcia Lira Neto, Francisca Sousa Lima Inácio, Thaimara Sousa Freitas Costa, Roberto Wagner Júnior Freire de Freitas, Marta Maria Coelho Damasceno, Maria do Livramento de Paula, Luis Fernando Costa Pereira, Camila Aparecida Pinheiro Landim Almeida, Carla Regina de Souza Teixeira, Márcio Flávio Moura de Araújo, José Claudio Garcia Lira Neto, Francisca Sousa Lima Inácio, Thaimara Sousa Freitas Costa, Roberto Wagner Júnior Freire de Freitas, Marta Maria Coelho Damasceno, Maria do Livramento de Paula, Luis Fernando Costa Pereira, Camila Aparecida Pinheiro Landim Almeida, Carla Regina de Souza Teixeira · 2026
Read Feasibility and preliminary biomarker responses to capsules containing green coffee extract enriched with magnesium di-malate in women with type 2 diabetes mellitus: a randomized, placebo-controlled pilot trial by Márcio Flávio Moura de Araújo, José Claudio Garcia Lira Neto, Francisca Sousa Lima Inácio, Thaimara Sousa Freitas Costa, Roberto Wagner Júnior Freire de Freitas, Marta Maria Coelho Damasceno, Maria do Livramento de Paula, Luis Fernando Costa Pereira, Camila Aparecida Pinheiro Landim Almeida, Carla Regina de Souza Teixeira, Márcio Flávio Moura de Araújo, José Claudio Garcia Lira Neto, Francisca Sousa Lima Inácio, Thaimara Sousa Freitas Costa, Roberto Wagner Júnior Freire de Freitas, Marta Maria Coelho Damasceno, Maria do Livramento de Paula, Luis Fernando Costa Pereira, Camila Aparecida Pinheiro Landim Almeida, Carla Regina de Souza Teixeira (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13456921.txt.
Description
Márcio Flávio Moura de Araújo and nine colleagues ran, in a 2026 pilot trial, a test of green coffee capsules boosted with magnesium in women with type 2 diabetes. Forty-eight women were split evenly between the real capsules and a placebo for twelve weeks, with neither side knowing which. Feasibility, meaning whether women would stay in and take the capsules, was the main question.
About 83 percent finished the study, and capsule taking ran above 82 percent, so the protocol proved workable. Blood sugar measures wobbled in both groups without a consistent edge for the real capsules. Triglycerides and a sugar-fat index drifted down numerically in the treated group, while uric acid rose and fell in both. The authors stress that a pilot of this size cannot settle benefit. Its value is proving the design, so a larger trial can test the early hints properly.
Catalog record
| CREATOR | Márcio Flávio Moura de Araújo, José Claudio Garcia Lira Neto, Francisca Sousa Lima Inácio, Thaimara Sousa Freitas Costa, Roberto Wagner Júnior Freire de Freitas, Marta Maria Coelho Damasceno, Maria do Livramento de Paula, Luis Fernando Costa Pereira, Camila Aparecida Pinheiro Landim Almeida, Carla Regina de Souza Teixeira, Márcio Flávio Moura de Araújo, José Claudio Garcia Lira Neto, Francisca Sousa Lima Inácio, Thaimara Sousa Freitas Costa, Roberto Wagner Júnior Freire de Freitas, Marta Maria Coelho Damasceno, Maria do Livramento de Paula, Luis Fernando Costa Pereira, Camila Aparecida Pinheiro Landim Almeida, Carla Regina de Souza Teixeira |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84434 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |